To promote in utero skin generation for the treatment of the severe developmental condition spina bifida, our research group developed a biomaterial composed of a porous type I collagen scaffold, functionalized with heparin, FGF2 and VEGF (COL-HEP/GF). The gene discussed is FGF2; the disease is spina bifida.